Company BioNexus Gene Lab Corp.

Equities

BGLC

US0906282076

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.5935 USD +0.15% Intraday chart for BioNexus Gene Lab Corp. -1.05% +11.98%

Business Summary

BioNexus Gene Lab Corp., through its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd., focuses on the wholesale of chemical raw material products. The Company is engaged in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. The Company is also engaged in the business of developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. Its non-invasive blood screening tests analyze changes in ribonucleic acid (RNA) to detect the risk potentiality of approximately 11 different diseases. It offers a range of fiberglass reinforced plastic (FRP) products, which include Polyester Resin SHCP 268, Polyester Resin 9509 and Polyester Resin 2802. The FRP and other raw materials it offers are used to produce a variety of goods, including handrails, bench tops, cleanroom panels, and covers for various instruments used in manufacturing.

Number of employees: 30

Sales per Business

USD in Million2022Weight2023Weight Delta
Chemrex
99.8 %
11 99.1 % 10 99.8 % -10.03%
MRNA Scientific Malaysia
0.2 %
0 0.9 % 0 0.2 % -74.72%

Sales per region

USD in Million2022Weight2023Weight Delta
Malaysia
100.0 %
11 100.0 % 10 100.0 % -10.60%

Managers

Managers TitleAgeSince
Chief Executive Officer 40 23-07-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 22-03-06
Director/Board Member 48 Dec. 10
Chief Executive Officer 40 23-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,667,663 6,294,165 ( 35.63 %) 0 35.63 %

Shareholders

NameEquities%Valuation
2,000,000 11.24 % 1 M $
1,666,667 9.367 % 1 M $
Soo Lai
7.025 %
1,250,001 7.025 % 882 501 $
1,166,673 6.557 % 823 671 $
1,041,706 5.855 % 735 444 $
1,031,427 5.797 % 728 187 $
Tham Kam
5.719 %
1,017,539 5.719 % 718 383 $
594,243 3.340 % 419 536 $
504,603 2.836 % 356 250 $
399,807 2.247 % 282 264 $

Company contact information

BioNexus Gene Lab Corp.

Tower B, Vertical Business Suite Bangsar South, 8 Jalan Kerinchi

59200, Kuala Lumpur

+60 1 2212 6512

http://www.bionexusgenelab.com
address BioNexus Gene Lab Corp.(BGLC)
  1. Stock Market
  2. Equities
  3. BGLC Stock
  4. Company BioNexus Gene Lab Corp.